Evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis C

BACKGROUND AND RATIONALE: Most patients with chronic hepatitis C show virological response to telaprevir-based triple therapy, and achieve an end-of-treatment response (ETR). However, some patients showing ETR develop virological relapse. This study was carried out to evaluate factors associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, C, Atsukawa, M, Tsubota, A, Shimada, N, Abe, H, Aizawa, Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944324/
https://www.ncbi.nlm.nih.gov/pubmed/26732192
http://dx.doi.org/10.4103/0022-3859.173191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944324/
https://www.ncbi.nlm.nih.gov/pubmed/26732192
http://dx.doi.org/10.4103/0022-3859.173191

Ejemplares similares